MedTech Barcelona
Contact information
- Cell cultures
- Drug development
- Drug discovery
- Substance abuse
- Analgesia & Pain
- Cosmetics
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Gynaecology and obstetrics
- Immunology
- Oncology
- Blood and lymphatic system
- Digestive system and hepatology
- Kidney and genitourinary system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
- Maintenance of cell cultures
Biotechnology company owned by Leitat that combines its expertise in cell culturing with its patented technology to deliver ready-to-use cell-based in vitro solutions. The current product pipeline includes several ready-to-use, in vitro, cell-based plates for drug discovery, ADME-Tox, and transporter research. Additionally, through collaborations with biotech companies and academia, MedTech Barcelona also facilitates the transportation of various cellular models using an advanced, proprietary shipping medium. Its high-quality solutions ensure reliable results, while supporting innovation, regulatory compliance, and sustainable research.
MedTech Barcelona´s product portfolio covers ready-to-use cellular kits with essential applications in drug discovery, such as absorption studies, drug-transporter interactions, and toxicity testing.
Development of ready-to use cellular kits for efficacy or safety studies involving different types of cultures (2D or 3D cultures, organoids,…), to cover market needs.